Twin Tree Management, LP Roivant Sciences Ltd. Transaction History
Twin Tree Management, LP
- $54.5 Billion
- Q4 2024
A detailed history of Twin Tree Management, LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Twin Tree Management, LP holds 1,100 shares of ROIV stock, worth $11,484. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,100
Previous 121,100
99.09%
Holding current value
$11,484
Previous $1.4 Million
99.07%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ROIV
# of Institutions
330Shares Held
511MCall Options Held
1.14MPut Options Held
1.26M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$688 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$687 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$565 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$460 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$369 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.35B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...